ID   GLNA_HUMAN              Reviewed;         373 AA.
AC   P15104; Q499Y9; Q5T9Z1; Q7Z3W4; Q8IZ17;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-JUL-2015, entry version 171.
DE   RecName: Full=Glutamine synthetase;
DE            Short=GS;
DE            EC=6.3.1.2;
DE   AltName: Full=Glutamate decarboxylase;
DE            EC=4.1.1.15;
DE   AltName: Full=Glutamate--ammonia ligase;
GN   Name=GLUL; Synonyms=GLNS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=2888076; DOI=10.1093/nar/15.15.6293;
RA   Gibbs C.S., Campbell K.E., Wilson R.H.;
RT   "Sequence of a human glutamine synthetase cDNA.";
RL   Nucleic Acids Res. 15:6293-6293(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1681907; DOI=10.1016/0167-4781(91)90111-X;
RA   van den Hoff M.J.B., Geerts W.J.C., Das A.T., Moorman A.F.M.,
RA   Lamers W.H.;
RT   "cDNA sequence of the long mRNA for human glutamine synthase.";
RL   Biochim. Biophys. Acta 1090:249-251(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=7909780;
RA   Christa L., Simon M.T., Flinois J.P., Gebhardt R., Brechot C.,
RA   Lasserre C.;
RT   "Overexpression of glutamine synthetase in human primary liver
RT   cancer.";
RL   Gastroenterology 106:1312-1320(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Haberle J., Koch H.G.;
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, Eye, Muscle, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain;
RX   PubMed=12387715; DOI=10.1023/A:1020574003027;
RA   Boksha I.S., Schonfeld H.J., Langen H., Muller F., Tereshkina E.B.,
RA   Burbaeva G.S.H.;
RT   "Glutamine synthetase isolated from human brain: octameric structure
RT   and homology of partial primary structure with human liver glutamine
RT   synthetase.";
RL   Biochemistry (Mosc.) 67:1012-1020(2002).
RN   [9]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=18662667; DOI=10.1016/j.abb.2008.07.009;
RA   Vermeulen T., Goerg B., Vogl T., Wolf M., Varga G., Toutain A.,
RA   Paul R., Schliess F., Haeussinger D., Haeberle J.;
RT   "Glutamine synthetase is essential for proliferation of fetal skin
RT   fibroblasts.";
RL   Arch. Biochem. Biophys. 478:96-102(2008).
RN   [10]
RP   INDUCTION.
RX   PubMed=18555765; DOI=10.1016/j.bone.2008.04.016;
RA   Olkku A., Mahonen A.;
RT   "Wnt and steroid pathways control glutamate signalling by regulating
RT   glutamine synthetase activity in osteoblastic cells.";
RL   Bone 43:483-493(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS CSGD CYS-324 AND CYS-341, AND CHARACTERIZATION OF VARIANTS
RP   CSGD CYS-324 AND CYS-341.
RX   PubMed=16267323; DOI=10.1056/NEJMoa050456;
RA   Haeberle J., Goerg B., Rutsch F., Schmidt E., Toutain A.,
RA   Benoist J.-F., Gelot A., Suc A.-L., Hoehne W., Schliess F.,
RA   Haeussinger D., Koch H.G.;
RT   "Congenital glutamine deficiency with glutamine synthetase
RT   mutations.";
RL   N. Engl. J. Med. 353:1926-1933(2005).
CC   -!- FUNCTION: This enzyme has 2 functions: it catalyzes the production
CC       of glutamine and 4-aminobutanoate (gamma-aminobutyric acid, GABA),
CC       the latter in a pyridoxal phosphate-independent manner (By
CC       similarity). Essential for proliferation of fetal skin
CC       fibroblasts. {ECO:0000250, ECO:0000269|PubMed:18662667}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-glutamate + NH(3) = ADP + phosphate +
CC       L-glutamine.
CC   -!- CATALYTIC ACTIVITY: L-glutamate = 4-aminobutanoate + CO(2).
CC   -!- COFACTOR:
CC       Name=biotin; Xref=ChEBI:CHEBI:57586; Evidence={ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Homooctamer and homotetramer. Interacts with PALMD (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-746653, EBI-746653;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Mitochondrion {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during early fetal stages.
CC       {ECO:0000269|PubMed:18662667}.
CC   -!- INDUCTION: By glucocorticoids. Vitamin D and the Wnt signaling
CC       pathway inhibit its expression and activity.
CC       {ECO:0000269|PubMed:18555765}.
CC   -!- PTM: Ubiquitinated by ZNRF1. {ECO:0000250}.
CC   -!- DISEASE: Congenital systemic glutamine deficiency (CSGD)
CC       [MIM:610015]: Rare developmental disorder with severe brain
CC       malformation resulting in multi-organ failure and neonatal death.
CC       Glutamine is largely absent from affected patients serum, urine
CC       and cerebrospinal fluid. {ECO:0000269|PubMed:16267323}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the glutamine synthetase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Glutamine synthetase entry;
CC       URL="http://en.wikipedia.org/wiki/Glutamine_synthetase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00387; CAA68457.1; -; mRNA.
DR   EMBL; X59834; CAA42495.1; -; mRNA.
DR   EMBL; S70290; AAB30693.1; -; mRNA.
DR   EMBL; AY486122; AAS57904.1; -; mRNA.
DR   EMBL; AY486123; AAS57905.1; -; Genomic_DNA.
DR   EMBL; BX537384; CAD97626.1; -; mRNA.
DR   EMBL; AL139344; CAI19842.1; -; Genomic_DNA.
DR   EMBL; BC010037; AAH10037.1; -; mRNA.
DR   EMBL; BC011700; AAH11700.1; -; mRNA.
DR   EMBL; BC011852; AAH11852.1; -; mRNA.
DR   EMBL; BC018992; AAH18992.1; -; mRNA.
DR   EMBL; BC031964; AAH31964.1; -; mRNA.
DR   EMBL; BC051726; AAH51726.1; -; mRNA.
DR   CCDS; CCDS1344.1; -.
DR   PIR; S18455; AJHUQ.
DR   RefSeq; NP_001028216.1; NM_001033044.3.
DR   RefSeq; NP_001028228.1; NM_001033056.3.
DR   RefSeq; NP_002056.2; NM_002065.6.
DR   RefSeq; XP_006711341.1; XM_006711278.1.
DR   UniGene; Hs.132016; -.
DR   UniGene; Hs.518525; -.
DR   PDB; 2OJW; X-ray; 2.05 A; A/B/C/D/E=5-365.
DR   PDB; 2QC8; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J=5-365.
DR   PDBsum; 2OJW; -.
DR   PDBsum; 2QC8; -.
DR   ProteinModelPortal; P15104; -.
DR   SMR; P15104; 10-365.
DR   BioGrid; 109014; 25.
DR   DIP; DIP-308N; -.
DR   IntAct; P15104; 19.
DR   MINT; MINT-1183856; -.
DR   STRING; 9606.ENSP00000307900; -.
DR   BindingDB; P15104; -.
DR   ChEMBL; CHEMBL4612; -.
DR   DrugBank; DB01212; Ceftriaxone.
DR   DrugBank; DB01119; Diazoxide.
DR   DrugBank; DB00130; L-Glutamine.
DR   DrugBank; DB00134; L-Methionine.
DR   DrugBank; DB00082; Pegvisomant.
DR   PhosphoSite; P15104; -.
DR   BioMuta; GLUL; -.
DR   REPRODUCTION-2DPAGE; IPI00010130; -.
DR   UCD-2DPAGE; P15104; -.
DR   MaxQB; P15104; -.
DR   PaxDb; P15104; -.
DR   PeptideAtlas; P15104; -.
DR   PRIDE; P15104; -.
DR   DNASU; 2752; -.
DR   Ensembl; ENST00000311223; ENSP00000307900; ENSG00000135821.
DR   Ensembl; ENST00000331872; ENSP00000356537; ENSG00000135821.
DR   Ensembl; ENST00000339526; ENSP00000344958; ENSG00000135821.
DR   Ensembl; ENST00000417584; ENSP00000398320; ENSG00000135821.
DR   GeneID; 2752; -.
DR   KEGG; hsa:2752; -.
DR   UCSC; uc001gpa.2; human.
DR   CTD; 2752; -.
DR   GeneCards; GC01M182350; -.
DR   HGNC; HGNC:4341; GLUL.
DR   HPA; CAB008636; -.
DR   HPA; HPA007316; -.
DR   HPA; HPA007571; -.
DR   MIM; 138290; gene.
DR   MIM; 610015; phenotype.
DR   neXtProt; NX_P15104; -.
DR   Orphanet; 71278; Congenital brain dysgenesis due to glutamine synthetase deficiency.
DR   PharmGKB; PA28743; -.
DR   eggNOG; COG0174; -.
DR   GeneTree; ENSGT00390000010047; -.
DR   HOGENOM; HOG000061500; -.
DR   HOVERGEN; HBG005847; -.
DR   InParanoid; P15104; -.
DR   KO; K01915; -.
DR   OMA; RIPRNVG; -.
DR   OrthoDB; EOG7CZK5G; -.
DR   PhylomeDB; P15104; -.
DR   TreeFam; TF300491; -.
DR   BioCyc; MetaCyc:HS06066-MONOMER; -.
DR   BRENDA; 6.3.1.2; 2681.
DR   Reactome; REACT_13639; Astrocytic Glutamate-Glutamine Uptake And Metabolism.
DR   Reactome; REACT_238; Amino acid synthesis and interconversion (transamination).
DR   SABIO-RK; P15104; -.
DR   ChiTaRS; GLUL; human.
DR   EvolutionaryTrace; P15104; -.
DR   GenomeRNAi; 2752; -.
DR   NextBio; 10840; -.
DR   PRO; PR:P15104; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; P15104; -.
DR   CleanEx; HS_GLUL; -.
DR   ExpressionAtlas; P15104; baseline and differential.
DR   Genevisible; P15104; HS.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0097386; C:glial cell projection; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016595; F:glutamate binding; IEA:Ensembl.
DR   GO; GO:0004351; F:glutamate decarboxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004356; F:glutamate-ammonia ligase activity; EXP:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:Ensembl.
DR   GO; GO:0030145; F:manganese ion binding; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome.
DR   GO; GO:0009267; P:cellular response to starvation; IEA:Ensembl.
DR   GO; GO:0006538; P:glutamate catabolic process; TAS:BHF-UCL.
DR   GO; GO:0006542; P:glutamine biosynthetic process; TAS:BHF-UCL.
DR   GO; GO:0001504; P:neurotransmitter uptake; TAS:Reactome.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0007268; P:synaptic transmission; TAS:Reactome.
DR   Gene3D; 3.30.590.10; -; 1.
DR   InterPro; IPR008147; Gln_synt_beta.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   InterPro; IPR008146; Gln_synth_cat_dom.
DR   InterPro; IPR027303; Gln_synth_gly_rich_site.
DR   InterPro; IPR027302; Gln_synth_N_conserv_site.
DR   Pfam; PF00120; Gln-synt_C; 1.
DR   Pfam; PF03951; Gln-synt_N; 1.
DR   SUPFAM; SSF54368; SSF54368; 1.
DR   PROSITE; PS00180; GLNA_1; 1.
DR   PROSITE; PS00181; GLNA_ATP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Disease mutation; Ligase; Lyase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330}.
FT   CHAIN         2    373       Glutamine synthetase.
FT                                /FTId=PRO_0000153139.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000269|PubMed:19413330}.
FT   MOD_RES     104    104       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P15105}.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   VARIANT     324    324       R -> C (in CSGD; reduced glutamine
FT                                synthetase activity).
FT                                {ECO:0000269|PubMed:16267323}.
FT                                /FTId=VAR_026560.
FT   VARIANT     341    341       R -> C (in CSGD; suggests reduced
FT                                glutamine synthetase activity).
FT                                {ECO:0000269|PubMed:16267323}.
FT                                /FTId=VAR_026561.
FT   CONFLICT      7      7       S -> Y (in Ref. 7; AAH31964).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       F -> L (in Ref. 5; CAD97626).
FT                                {ECO:0000305}.
FT   CONFLICT    155    155       P -> T (in Ref. 7; AAH31964).
FT                                {ECO:0000305}.
FT   CONFLICT    314    314       A -> G (in Ref. 1; CAA68457).
FT                                {ECO:0000305}.
FT   CONFLICT    322    323       SI -> RL (in Ref. 2; CAA42495).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       D -> E (in Ref. 2; CAA42495).
FT                                {ECO:0000305}.
FT   HELIX         5      8       {ECO:0000244|PDB:2OJW}.
FT   HELIX        11     18       {ECO:0000244|PDB:2OJW}.
FT   STRAND       26     33       {ECO:0000244|PDB:2OJW}.
FT   STRAND       40     49       {ECO:0000244|PDB:2OJW}.
FT   HELIX        54     56       {ECO:0000244|PDB:2OJW}.
FT   STRAND       60     63       {ECO:0000244|PDB:2OJW}.
FT   TURN         64     68       {ECO:0000244|PDB:2OJW}.
FT   STRAND       69     71       {ECO:0000244|PDB:2OJW}.
FT   HELIX        72     74       {ECO:0000244|PDB:2QC8}.
FT   STRAND       76     86       {ECO:0000244|PDB:2OJW}.
FT   TURN         88     90       {ECO:0000244|PDB:2OJW}.
FT   STRAND       95    102       {ECO:0000244|PDB:2OJW}.
FT   STRAND      106    108       {ECO:0000244|PDB:2QC8}.
FT   HELIX       114    123       {ECO:0000244|PDB:2OJW}.
FT   HELIX       124    127       {ECO:0000244|PDB:2OJW}.
FT   STRAND      130    140       {ECO:0000244|PDB:2OJW}.
FT   STRAND      144    146       {ECO:0000244|PDB:2QC8}.
FT   STRAND      158    160       {ECO:0000244|PDB:2OJW}.
FT   TURN        167    169       {ECO:0000244|PDB:2OJW}.
FT   HELIX       173    186       {ECO:0000244|PDB:2OJW}.
FT   STRAND      190    195       {ECO:0000244|PDB:2OJW}.
FT   STRAND      201    210       {ECO:0000244|PDB:2OJW}.
FT   HELIX       213    232       {ECO:0000244|PDB:2OJW}.
FT   STRAND      235    237       {ECO:0000244|PDB:2OJW}.
FT   STRAND      245    247       {ECO:0000244|PDB:2OJW}.
FT   STRAND      251    257       {ECO:0000244|PDB:2OJW}.
FT   HELIX       259    262       {ECO:0000244|PDB:2OJW}.
FT   TURN        264    266       {ECO:0000244|PDB:2OJW}.
FT   HELIX       267    278       {ECO:0000244|PDB:2OJW}.
FT   HELIX       281    287       {ECO:0000244|PDB:2OJW}.
FT   TURN        290    295       {ECO:0000244|PDB:2OJW}.
FT   HELIX       296    298       {ECO:0000244|PDB:2OJW}.
FT   STRAND      314    316       {ECO:0000244|PDB:2OJW}.
FT   STRAND      321    325       {ECO:0000244|PDB:2OJW}.
FT   HELIX       327    332       {ECO:0000244|PDB:2OJW}.
FT   STRAND      337    339       {ECO:0000244|PDB:2OJW}.
FT   HELIX       348    359       {ECO:0000244|PDB:2OJW}.
SQ   SEQUENCE   373 AA;  42064 MW;  45390C100924FAF3 CRC64;
     MTTSASSHLN KGIKQVYMSL PQGEKVQAMY IWIDGTGEGL RCKTRTLDSE PKCVEELPEW
     NFDGSSTLQS EGSNSDMYLV PAAMFRDPFR KDPNKLVLCE VFKYNRRPAE TNLRHTCKRI
     MDMVSNQHPW FGMEQEYTLM GTDGHPFGWP SNGFPGPQGP YYCGVGADRA YGRDIVEAHY
     RACLYAGVKI AGTNAEVMPA QWEFQIGPCE GISMGDHLWV ARFILHRVCE DFGVIATFDP
     KPIPGNWNGA GCHTNFSTKA MREENGLKYI EEAIEKLSKR HQYHIRAYDP KGGLDNARRL
     TGFHETSNIN DFSAGVANRS ASIRIPRTVG QEKKGYFEDR RPSANCDPFS VTEALIRTCL
     LNETGDEPFQ YKN
//
